ADC Therapeutics (ADCT) Amortization of Deferred Charges: 2023
Historic Amortization of Deferred Charges for ADC Therapeutics (ADCT) over the last 1 years, with Dec 2023 value amounting to $694,000.
- ADC Therapeutics' Amortization of Deferred Charges was N/A to $694,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $3.0 million, marking a year-over-year change of. This contributed to the annual value of $902,000 for FY2024, which is 70.09% down from last year.
- Latest data reveals that ADC Therapeutics reported Amortization of Deferred Charges of $694,000 as of Q4 2023, which was down 15.26% from $819,000 recorded in Q3 2023.
- In the past 5 years, ADC Therapeutics' Amortization of Deferred Charges registered a high of $830,000 during Q1 2023, and its lowest value of $673,000 during Q2 2023.
- Over the past 1 years, ADC Therapeutics' median Amortization of Deferred Charges value was $756,500 (recorded in 2023), while the average stood at $754,000.